News Column

Jiuzhitang H1 Net Up 11.54%, Cost Pressure Down

July 30, 2014

HUNAN, July 30, SinoCast -- Jiuzhitang (SZSE: 000989) recorded operating revenue of CNY 665 million in the first half of this year, growing 8.95% over a year earlier.

Net profits hit CNY 72.59 million, growing 11.54%.

Operating revenue from Chinese patent drugs hit CNY 470 million and the cost dropped 4.20%; gross margin was 63.13%, growing 3.33 percentage points.

Raw materials cost accounted for 62.47% of the entire pharmaceutical industry's cost. The price all of traditional Chinese medicinal materials it needed in the first half of this year dropped to alleviate the cost pressure.

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Sinocast Health Care & Medicine Beat (China)

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters